1. Home
  2. OPRX vs PRQR Comparison

OPRX vs PRQR Comparison

Compare OPRX & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OptimizeRx Corporation

OPRX

OptimizeRx Corporation

HOLD

Current Price

$13.36

Market Cap

261.5M

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$2.34

Market Cap

250.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPRX
PRQR
Founded
2006
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
261.5M
250.7M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
OPRX
PRQR
Price
$13.36
$2.34
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$14.83
$8.14
AVG Volume (30 Days)
221.9K
540.5K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$109,506,000.00
$18,859,556.00
Revenue This Year
$19.77
N/A
Revenue Next Year
$11.33
N/A
P/E Ratio
$7,312.30
N/A
Revenue Growth
24.18
N/A
52 Week Low
$3.99
$1.07
52 Week High
$22.25
$3.46

Technical Indicators

Market Signals
Indicator
OPRX
PRQR
Relative Strength Index (RSI) 34.62 53.75
Support Level $13.14 $2.15
Resistance Level $14.95 $2.42
Average True Range (ATR) 0.66 0.19
MACD 0.05 0.04
Stochastic Oscillator 14.05 79.70

Price Performance

Historical Comparison
OPRX
PRQR

About OPRX OptimizeRx Corporation

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: